Page last updated: 2024-08-23

alkenes and Ovarian Neoplasms

alkenes has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caligiuri, I; Canovese, L; Demitri, N; Gambari, R; Lampronti, I; Rizzolio, F; Santo, C; Scattolin, T; Visentin, F1
Brouwer, J; den Dulk, H; Marqués-Gallego, P; Mutikainen, I; Reedijk, J; Tanase, S; Turpeinen, U1
Aubert, G; Bourg, S; Chapleur, Y; Cresteil, T; Dubois, J; Novoa, A; Pellegrini-Moïse, N; Thoret, S1

Other Studies

3 other study(ies) available for alkenes and Ovarian Neoplasms

ArticleYear
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines.
    Dalton transactions (Cambridge, England : 2003), 2018, Oct-02, Volume: 47, Issue:38

    Topics: Alkenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Female; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Ligands; Methane; Organometallic Compounds; Ovarian Neoplasms; Palladium; Purines

2018
Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand.
    Biochemical pharmacology, 2009, Aug-15, Volume: 78, Issue:4

    Topics: Alkenes; Cisplatin; Crystallography, X-Ray; Diamines; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorescence; Humans; Ovarian Neoplasms; Photochemical Processes; Platinum; Tumor Cells, Cultured

2009
Design, synthesis and antiproliferative activities of biarylolefins based on polyhydroxylated and carbohydrate scaffolds.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:9

    Topics: Alkenes; Carbohydrates; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Tubulin

2011